Congenica
Wellcome Genome Campus
Hinxton
Cambridge
CB10 1DR
United Kingdom
Tel: 44-1223-499-965
Website: https://www.congenica.com/
Email: info@congenica.com
About Congenica
Congenica is a UK company founded on pioneering research from the Wellcome Trust Sanger Institute, NHS clinicians and regional genetic testing laboratories. We’ve translated this research into the gold standard clinical genomic analytics platform, Sapientia®, providing integration of human DNA sequences with deep clinical phenotyping, enabling clinicians to provide actionable interpretation of genetic disease for patients.YEAR FOUNDED:
2014
LEADERSHIP:
CEO: Thomas Weaver
COO: Nick Lench
PRODUCTS:
Please click here for Congenica's products.
25 articles about Congenica
-
GenomOncology and Congenica Announce Collaborative Development of Novel Precision Oncology Solution
8/4/2022
Congenica, a UK-based digital health company that enables the rapid analysis and interpretation of genomic data, has selected the GenomOncology Precision Oncology Platform for the development of a novel ground-breaking CE-IVD Precision Oncology Solution.
-
Congenica Appoints Dr. Tom Barber as Chief Scientific Officer
5/3/2022
Congenica announces the appointment of Dr. Tom Barber as Chief Scientific Officer.
-
Congenica to Provide Tertiary Analysis for Whole Genome Sequencing for Hong Kong Genome Project
3/16/2022
Congenica to Provide Tertiary Analysis for Whole Genome Sequencing for Hong Kong Genome Project.
-
Congenica Receives CE Mark for Genomic Analysis Software
7/21/2021
Congenica Receives CE Mark for Genomic Analysis Software Cambridge, United Kingdom.
-
Congenica Automation Further Accelerates Identification of Genetic Diseases
7/15/2020
Congenica , a digital health company enabling rapid analysis of complex genomic data, has launched an update for its clinical decision support platform that will provide automated classification, evidence and reporting of recurrent 'known' variants that customers observe in their rare disease cases, significantly saving time wh
-
Congenica Appoints Dr. Heiner Dreismann as Non-Executive Director
11/5/2019
Congenica Ltd, a pioneering digital health company enabling accelerated interpretation of complex genomic data to improve disease characterization and diagnosis, has announced the appointment of Dr Heiner Dreismann as non-executive Director and Senior Independent Director on the board.
-
Congenica simplifies software branding and enhances platform with CNV calling to deliver genomic medicine globally
7/22/2019
Congenica, a digital health company enabling accelerated genomic data interpretation, today announced it has renamed its software platformCongenica® and expanded its capabilities to include CNV calling for exome and gene panel sequencing.
-
Congenica Co-founder and Scientific Director Dr Matthew Hurles Elected to Fellowship of the Royal Society
4/18/2019
Congenica, the global diagnostic decision support platform provider, congratulates its co-founder and Scientific Director, Dr Matthew Hurles, FMedSci FRS, who has been elected to Fellowship of the Royal Society, the UK’s most prestigious scientific organisation.
-
Congenica Announces On-Premise Deployment Option for its SapientiaTM Platform
4/1/2019
Congenica, the global diagnostic decision support platform provider, has announced that it now offers an on-premise deployment method in addition to cloud deployment for running its SapientiaTM platform.
-
Epilepsy Society, UCL and Congenica Join Forces in Genomic Study to Identify Causes of Unexpected Deaths in Epilepsy
10/23/2018
Sudden unexpected death in epilepsy (SUDEP) occurs in approximately 1/1000 people with epilepsy and is poorly understood
-
Congenica Earns Major Role in Supporting World’s First Routine National Genomic Medicine Service
10/17/2018
Genomics England names Congenica as its Clinical Decision Support Service partner for the delivery of the NHS Genomic Medicine Service
-
Congenica Announces Market Access Partnership with Digital China Health to Enable Genomic Medicine in the Chinese Market
9/17/2018
Partnership will accelerate Congenica’s commercial expansion in the Chinese market
-
Congenica Appoints Wendy Britten as Chief Financial Officer
8/28/2018
Congenica, the global provider of clinical genomics interpretation software, today announced the appointment of Mrs Wendy Britten as its new Chief Financial Officer (CFO), effective 1st September, 2018.
-
Congenica and SFI Research Centre FutureNeuro Unite to Deliver More Accurate Diagnoses for Genetic Epilepsy
2/12/2018
The alliance between Congenica and FutureNeuro, will further help the evolving understanding of the causes of many types of epilepsy and will also help to progress the exciting clinical alliance between genomics and electronic health records.
-
Congenica Signs Strategic Digital Health Contracts During Official UK-China Trade Mission
2/1/2018
The meeting was held in conjunction with the State visit of Prime Minister May.
-
Congenica Appoints New CEO to Drive Global Expansion of Clinical Genomics Business
1/25/2018
Congenica today announced the appointment of its new Chief Executive Officer, David Atkins, Ph.D. Based at the Company’s headquarters in Cambridge, UK.
-
Congenica’s Sapientia Selected By Coimbra Paediatric Hospital For Portugal’s In2genome Genetic Disease Diagnosis Project
9/6/2017
-
China's BGI And Healthlink Invest And Make Deal With UK's Congenica
4/28/2017
-
Congenica Completes Series B Financing Round With Investments From China-Based BGI Healthlink And Future Planet
4/27/2017
-
Congenica And Edico Genome Partner To Speed Analysis From 'DNA To Diagnosis' For Inherited Diseases
4/20/2017